Jenburkt Pharmaceuticals Ltd — Important, 04-09-2026: Company Update

The company's shareholders at the 41st Annual General Meeting have approved the re-appointment of Shri Dilip H. Bhuta as Whole Time Director and CFO for a period of five years, effective from April 1, 2027, to March 31, 2032. His remuneration has also been approved for three years starting April 1, 2027. Shri Bhuta, 74, has been with the company's Board since 2013 and brings extensive experience in finance and operations from his long career, including as Managing Director of BOB Cards Ltd. This re-appointment ensures continued leadership in key financial and operational roles.